Annual Congress Vienna 2012

Saturday, 01.09.2012
Sunday, 02.09.2012
Monday, 03.09.2012
Tuesday, 04.09.2012
Wednesday, 05.09.2012

Citations should be made in the following way: Authors. Title. Eur Respir J 2012; 40: Suppl. 56, abstract number.

Pro/Con Debate "Cost-effectiveness of maintenance chemotherapy for NSCLC"

Symposium
Chairs: T. Berghmans (Brussels, Belgium), L. Schmidt (Munster, Germany)
Aims: Maintenance chemotherapy has been shown to be associated with improved outcomes for patients with advanced non-small cell lung cancer. However, the definition of maintenance is variable, the data published in the literature are heterogeneous and the cost of the drugs with which there is a potential benefit is high. The purpose of the session will be to discuss the practical advantages and disadvantages of maintenance in order to allow better therapeutic evidence-based decisions.

Download all media

PRO: maintenance is cost-effective R. Pirker (Vienna, Austria)
CON: maintenance is not cost-effective L. Horvath (Sydney, Australia)